Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
Sponsor: Valbiotis
Summary
This clinical study aims to assess the efficacy of TOTUM-854, a mix of 6 plant extracts, consumed twice a day on automated office blood pressure in subjects with moderately elevated blood pressure. The hypothesis is that TOTUM-854 is superior to placebo for decrease of automated office blood pressure after 12 weeks of consumption.
Official title: A Randomized, Placebo-controlled, Double-blind Study to Assess the Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
410
Start Date
2022-07-15
Completion Date
2024-12-01
Last Updated
2024-04-23
Healthy Volunteers
No
Interventions
TOTUM-854
12 weeks of TOTUM-854 supplementation
Placebo
12 weeks of placebo supplementation
Locations (10)
Multiprofile Hospital for Active Treatment Cardiology Department
Haskovo, Bulgaria
Multiprofile Hospital for Active Treatment - Uni Hospital OOD, Cardiology Department
Panagyurishte, Bulgaria
Diagnostic Consultative Center VII-Plovdiv South district EOOD, Cabinet of Endocrinology
Plovdiv, Bulgaria
Multiprofile Hospital for Active Treatment Sveta Karidad EAD, Cardiology Department
Plovdiv, Bulgaria
Diagnostic Consultative Center XX- Sofia EOOD
Sofia, Bulgaria
CHU Clermont Ferrand PIC/CIC Inserm 1405
Clermont-Ferrand, France
Vitamed Gałaj i Cichomski sp.j
Bydgoszcz, Poland
Centrum Medyczne Linden
Krakow, Poland
Przychodnia Zespołu Lekarza Rodzinnego "Medyk"
Słupca, Poland
Centrum Medyczne Oporów
Wroclaw, Poland